Eupraxia Pharmaceuticals (EPRX) Enterprise Value (2024 - 2026)
Eupraxia Pharmaceuticals' Enterprise Value was $128.85 million in the quarter ended Jun 30, 2026, down 30.0% from $183.95 million a year earlier and down 13.4% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Enterprise Value (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eupraxia Pharmaceuticals' Enterprise Value was -$179.56 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was $219.51 million, up 180.3% from the prior year.
- In earlier years, Enterprise Value was $78.32 million in the year ended Dec 31, 2024.
- Quarterly Enterprise Value has moved between $45.58 million (the quarter ended Jun 30, 2024) and $219.51 million (the quarter ended Dec 31, 2025) over five years.
- Compared with a year earlier, Enterprise Value was higher in four of the last five quarters, with growth averaging 123.6%.
- Per Business Quant data, EPRX's Enterprise Value in the three quarters before the quarter ended Jun 30, 2026 was $148.81 million (quarter ended Mar 31, 2026), $219.51 million (quarter ended Dec 31, 2025) and $119.74 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 128.85 Mn |
| Mar 31, 2026 | 148.81 Mn |
| Dec 31, 2025 | 219.51 Mn |
| Sep 30, 2025 | 119.74 Mn |
| Jun 30, 2025 | 183.95 Mn |
| Mar 31, 2025 | 87.88 Mn |
| Dec 31, 2024 | 78.32 Mn |
| Sep 30, 2024 | 61.55 Mn |
| Jun 30, 2024 | 45.58 Mn |
API Access
Eupraxia Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();